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Background: Brain tumors are highly aggressive tumors characterized by secretions of high levels of matrix metalloproteinase-2 and 
-9, leading to tumor growth, invasion and metastasis by digesting the basement membrane and extracellular matrix components. 
We previously demonstrated the effectiveness of a nutrient mixture (NM) containing ascorbic acid, lysine, proline, and green tea 
extract in vitro: on activity of urokinase plasminogen activator, matrix metalloproteinases and TIMPs in various human glioblas-
toma (LN-18, T-98G and A-172) cell lines and on glioblastoma A-172 cell proliferation and Matrigel invasion. Aim: Our main 
objective in this study was to investigate the effect of the NM in vivo on human glioblastoma U-87 MG cell line. Materials and 
Methods: Athymic male nude mice inoculated with 3·106 U-87 MG cells subcutaneously and were fed a regular diet or a regular 
diet supplemented with 0.5% NM. Four weeks later, the mice were sacrificed, the tumors were weighed and measured. The samples 
were studied histologically. Results: NM inhibited tumor weight and tumor burden by 53% (p = 0.015) and 48% (p = 0.010), re-
spectively. Conclusions: These results suggest the therapeutic potential of NM as an adjuvant in the treatment of glioblastoma.
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Approximately 22,850 new cases and 15,320 deaths 
from brain and nervous system tumors were estimated 
in the United States for adults in 2015 [1]. Brain cancer 
(mainly gliomas and medulloblastomas) is the second 
(after leukemia) leading cause of cancer death in chil-
dren aged under 20, accounting for one third of all 
cancer deaths in this age group [2]. Though most brain 
tumors tend not to metastasize to distant areas outside 
the brain and/or spinal cord, they do tend to recur lo-
cally, or spread to other areas of the central nervous 
system. Tumor cell invasion depends upon degrada-
tion of the extracellular matrix, which, when intact, acts 
as a barrier to block cancer cell invasion [3, 4]. Rath 
and Pauling proposed a universal approach to tumor 
growth and expansion using nutrients such as lysine 
and ascorbic acid to target plasmin-mediated con-
nective tissue degradation [5]. Subsequent studies 
confirmed this approach and led to identifying a novel 
formulation composed of lysine, ascorbic acid, pro-
line and green tea extract and other micronutrients, 
which has shown significant anticancer activity against 
a large number (~40) of cancer cell lines, blocking 
cancer growth, tissue invasion and matrix metallopro-
teinase (MMP) expression both in vitro and in vivo [6].
In a previous in vitro study, the nutrient mixture 
(NM) significantly inhibited urokinase plasminogen 
activator (uPA) and MMP secretion and increased 
TIMP-2 secretion in glioma cell lines [7]. Other stu-
dies found significant inhibition of cell proliferation and 
Matrigel invasion of glioma cell line A-172 by NM [8] 
and significant negative correlation between NM inhi-
bition of Matrigel invasion and NM modulation of the 
MMP-2 activity of glioma cell line A-172 [9]. Our main 
objective in this study was to investigate the effect 
of NM in vivo using human glioblastoma U-87 MG xe-
nografts in male nude mice.
MATERIALS AND METHODS
Cell line and NM. Human glioblastoma cell line 
U-87 MG was obtained from ATCC (American Type 
Culture Collection, Rockville, MD, USA). The NM, pre-
pared by VitaTech (Hayward, CA), was composed of the 
following ingredients in the amounts indicated: Vitamin 
C (as ascorbic acid and as Mg, Ca, and palmitate ascor-
bate) 700 mg; L-lysine 1000 mg; L-proline 750 mg; 
L-arginine 500 mg; N-acetyl cysteine 200 mg; stan-
dardized green tea extract (80% polyphenol) 1000 mg; 
selenium 30 μg; copper 2 mg; manganese 1 mg.
Animals. Male nude mice, approximately 5 weeks 
of age on arrival, were purchased from Simonsen 
Labo ratories, Gilroy, CA, and maintained in microiso-
lator cages under pathogen-free conditions on a 12-
hour light/12-hour dark schedule for a week. All pro-
cedures were performed according to humane and 
customary care and use of experimental animals and 
followed a protocol approved by internal institutional 
animal safety review committee.
Experimental design. After housing for a week, 
the mice (n = 12) were inoculated subcutaneously 
with 3•106 glioblastoma U-87 MG cells in 0.2 ml PBS 
and 0.1 ml Matrigel (BD Bioscience, Bedford, MA). 
After injection, the mice were randomly divided into 
two groups; the control group of mice was fed regular 
Laboratory Rodent Diet 5001 from Purina Mills, LLC 
(Gray Summit, MO, USA). and the NM group — the 
regular diet supplemented with 0.5% NM (w/w). The 
0.5% NM diet was milled and pressed by Purina Mills, 
LLC and generated by Vitatech (Tustin, CA, USA). 
During the study, the mice consumed, on the average, 
4 g of their respective diets per day. Thus, the supple-
mented mice received approximately 20 mg of NM per 
day. After four weeks, the mice were sacrificed and 
their tumors were excised and processed for histo logy. 
Dimensions (length and width) of tumors were mea-
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sured using a digital caliper, and the tumor burden was 
calculated using the following formula: 0.5 × length × 
width. Mean weight of mice at initiation of study and 
termination of study did not differ significantly between 
the groups.
Histology. Tissue samples were fixed in 10% buf-
fered formalin. All tissues were embedded in paraffin 
and cut at 4–5 microns. Sections were deparaffinized 
through xylene and graduated alcohol series to water 
and stained with hematoxylin and eosin (H & E) for 
evaluation using a standard light microscope.
Statistical analysis. The results were expressed 
as means ± SD and analyzed by independent sample 
“t” test using MedCalc software (Mariakerke, Bel-
gium).
RESULTS AND DISCUSSION
NM strongly inhibited the growth of U-87 MG xe-
nografts in male nude mice. Mean tumor weight was 
inhibited by 53% (p = 0.0147) with NM 0.5% dietary 
supplementation, as shown in Fig. 1, a and tumor 
burden was inhibited by 48% (p = 0.0098), as shown 
in Fig. 1, b. There was no significant difference be-
tween mean body weights of groups of mice.
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Fig. 1. Effect of NM on mean tumor weight (a) and tumor burden 
(b) in nude mice grafted with U-87 MG cells. *p = 0.015 (a) and 
p = 0.01 (b) as compared to control
Histologically, the tumors from both groups were 
irregularly round, subcutaneous masses, composed 
of solid sheets and nests of irregularly round epithe-
lioid cells with prominent round to ovoid nuclei and 
lightly staining bluish cytoplasm with ill-defined cell 
borders. Tumors from control and NM-supplemented 
mice were similar morphologically, but the tumors from 
supplemented mice were significantly smaller in size. 
Areas of tumor necrosis ranged from 50–80% of tu-
mor mass in the control group compared to 10–60% 
in the NM group. Areas of tumor necrosis were associ-
ated with moderate to severe neutrophilic infiltration 
(Fig. 2, a–d).
Previous in vitro results from the cellular proliferation 
study of glioblastoma A-172 support the in vivo find-
ings, as NM showed increased toxicity in cells in a dose-
dependent manner, with 50% inhibition of cell growth 
in cells exposed to 1000 μg/ml NM and total block 
of invasion through Matrigel at 1000 μg/ml NM [8]. 
In addition, prior studies of seve ral glioblastoma cell 
lines, demonstrated potent, significant suppression 
of invasive parameters by the NM, including uPA and 
MMP-2 and -9 [7].
Brain cancer is the second leading cause of cancer 
death in children under 20 years, accounting for one 
third of all cancer deaths in this age group. Current 
treatment methods for gliomas are generally ineffec-
tive and toxic. Thus, there is a need for development 
of effective therapeutic agents for these cancers with 
minimal toxicity. Our studies demonstrated that the 
mixture of the non-toxic components of NM signifi-
cantly inhibited the growth and tumor burden of glio-
blastoma cell line U-87 MG in vivo. These results 
in addition to our prior in vitro studies with glioblastoma 
cell lines, which documented significant inhibition 
of MMP-2 and-9 secretion and invasion by NM, sug-
gest the potential of NM as an adjuvant in treatment 
of glioblastomas.
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Fig. 2. Histopathology of tumors from control (a, b) and NM-
supplemented (c, d) mice, × 200. In b and d tumor necrosis and 
associated neutrophilic inflammation are present
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